Efficacy, safety, and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multicenter retrospective cohort study
新辅助曲妥珠单抗和帕妥珠单抗联合化疗治疗中国HER2阳性乳腺癌患者的疗效、安全性和生物标志物：一项多中心回顾性队列研究
期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003551
Qi, Xiaowei; Hu, Hong; Qiu, Pengfei; Chen, Wenlin; Wang, Xiaochun; Shi, Qiyun; Xu, Yan; Liu, Shu; Fang, Yanman; Li, Taolang; Ming, Jia; Zhou, Sihai; Chai, Fan; Liang, Yueyang; Fan, Yuanming; Tang, Peng; Chen, Li; Wang, Shushu; Jiang, Jun; Wang, Mengyuan; Zhang, Yi; Nie, Jianyun; Wang, Yongsheng
